[1] An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine

[2] Spectrum and activity of three contemporary fluoroquinolones tested against Pseudomonas aeruginosa isolates from urinary tract infections in the SENTRY Antimicrobial Surveillance Program (Europe and the Americas; 2000): more alike than different!

[3] Respiratory virus immunization. I. A field trial of two inactivated respiratory virus vaccines; an aqueous trivalent parainfluenza virus vaccine and an alum-precipitated respiratory syncytial virus vaccine

[4] Performance of premarket rapid hepatitis C virus antibody assays in 4 national human immunodeficiency virus behavioral surveillance system sites

[5] Survey of bloodstream infections due to gram-negative bacilli: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, and Latin America for the SENTRY Antimicrobial Surveillance Program, 1997

[6] Susceptibility to fluoroquinolones among commonly isolated Gram-negative bacilli in 2000: TRUST and TSN data for the United States. Tracking Resistance in the United States Today. The Surveillance Network

[7] Effects of vaccination on invasive pneumococcal disease in South Africa

[8] Geographic variations in activity of broad-spectrum beta-lactams against Pseudomonas aeruginosa: summary of the worldwide SENTRY Antimicrobial Surveillance Program (1997-2000)

[9] Macrolide resistance and emm type distribution of invasive pediatric group A streptococcal isolates: three-year prospective surveillance from a children's hospital

[10] The laboratory confirmation of suspected measles cases in settings of low measles transmission: conclusions from the experience in the Americas

[11] Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine

[12] Quinolone-resistant Campylobacter jejuni infections in Minnesota, 1992-1998. Investigation Team

[13] Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee

[14] Methicillin-resistant Staphylococcus aureus disease in three communities

[15] Spectrum of disease in persons with human immunodeficiency virus infection in the United States

[16] Variation in severity of respiratory syncytial virus infections with subtype

[17] Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine

[18] Epidemiology of human plague in the United States, 1900-2012

[19] Trends in antimicrobial resistance in bloodstream infection isolates at a large urban hospital in Malawi (1998-2016): a surveillance study

[20] Bacterial meningitis in the United States, 1978 through 1981. The National Bacterial Meningitis Surveillance Study

[21] Tetanus surveillance--United States, 1998--2000

[22] Surveillance for acute viral hepatitis - United States, 2007

[23] Field evaluation of a respiratory syncytial virus vaccine and a trivalent parainfluenza virus vaccine in a pediatric population

[24] Botulism in the United States: a clinical and epidemiologic review

[25] Geographic dependence, surveillance, and origins of the 2009 influenza A (H1N1) virus

[26] Secular trends in social patterning of cardiovascular risk factor levels in Sweden. The Northern Sweden MONICA Study 1986-1994. Multinational Monitoring of Trends and Determinants in Cardiovascular Disease

[27] Coronary risk factor levels: differences between educational groups in 1972-87 in eastern Finland

[28] Incidence of community-acquired pneumonia requiring hospitalization. Results of a population-based active surveillance Study in Ohio. The Community-Based Pneumonia Incidence Study Group

[29] Evaluation of universal antenatal screening for group B streptococcus

[30] The emergence in Taiwan of fluoroquinolone resistance in Salmonella enterica serotype choleraesuis

[31] National survey of Escherichia coli causing extraintestinal infections reveals the spread of drug-resistant clonal groups O25b:H4-B2-ST131, O15:H1-D-ST393 and CGA-D-ST69 with high virulence gene content in Spain

[32] Group A streptococcal infections in injection drug users in Barcelona, Spain: epidemiologic, clinical, and microbiologic analysis of 3 clusters of cases from 2000 to 2003

[33] Human plague occurrences in Africa: an overview from 1877 to 2008

[34] Candidemia in cancer patients: a prospective, multicenter surveillance study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC)

[35] Systematic analysis of the scientific literature on population surveillance.